Nausea is the most common, with relative risk ratios of 2.69 at 4 mg, 4.27 at 8 mg, and 4.00 at 12 mg compared to placebo
Advocacy and Support: Individuals using semaglutide might require advocacy and support, particularly in navigating the complex requirements related to drug testing in the workplace or in other contexts
How Passion Health Helps You Choose the Right GLP-1 Treatment At Passion Health Primary Care, our experienced providers help you navigate GLP-1 medications with a personalized, evidence-based approach
Semaglutide is available in various forms, including once-weekly injections, which can be more convenient than daily medications
Losing significant weight reduces the mechanical load on joints, and the anti-inflammatory effects of improved metabolic health further reduce pain and swelling